Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: an intervention study

Infectious Diseases of Poverty

Jian Mei²  Merav Kliner⁵  Huaixia Yang³  John Walley⁵  Jia Yin⁴  Guanyang Zou⁴  Xiaolin Wei¹ 

[1] School of Public Health and Primary Care, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, NT, Hong Kong, China;Shanghai Center for Disease Control and Prevention, No. 1380 Zhongshan Xi Rd, Shanghai, China;Shanghai Changning District Center for Disease Control and Prevention, No.39 Yun Wu Shan Rd, Shanghai, China;COMDIS China Program, Nuffield Centre for International Health and Development, University of Leeds, Room 403, No. 1032 Dongmen North Rd, Luohu District, Shenzhen, 518003, China;Nuffield Center for International Health and Development, University of Leeds, 101 Clarendon Rd, Leeds, LS2 9LJ, UK

关键词: Effectiveness;    Treatment completion;    Financial incentive;    Poverty;    Domestic migrants;    Tuberculosis;    Public health;   

Others  :  805640
DOI  :  10.1186/2049-9957-1-9

 received in 2012-08-23, accepted in 2012-10-04,  发布年份 2012

【 摘 要 】

Background

Financial issues are major barriers for rural-to-urban migrants accessing tuberculosis (TB) care in China. This paper discusses the effectiveness of providing financial incentives to migrant TB patients (with a focus on poor migrants in one district of Shanghai using treatment completion and default rates), the effect of financial incentives in terms of reducing the TB patient cost, and the incremental cost-effectiveness ratio of the intervention.

Results

Ninety and ninety-three migrant TB patients were registered in the intervention and control districts respectively. TB treatment completion rates significantly improved by 11% (from 78% to 89%) in the intervention district, compared with only a 3% increase (from 73% to 76%) in the control district (P = 0.03). Default rates significantly decreased by 11% (from 22% to 11%) in the intervention district, compared with 1% (from 24% to 23%) in the control district (P = 0.03). In the intervention district, the financial subsidy (RMB 1,080/US$170) accounted for 13% of the average patient direct cost (RMB 8,416/US$1,332). Each percent increase in treatment completion costs required an additional RMB 6,550 (US$1,301) and each percent reduction in defaults costs required an additional RMB 5,240 (US$825) in the intervention district.

Conclusions

Overall, financial incentives proved to be effective in improving treatment completion and reducing default rates among migrant TB patients in Shanghai. The results suggest that financial incentives can be effectively utilized as a strategy to enhance case management among migrant TB patients in large cities in China, and this strategy may be applicable to similar international settings.

【 授权许可】

   
2012 Wei et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 4.

【 参考文献 】

• [1]Liu JJ, Yao HY, Liu EY: Analysis of factors affecting the epidemiology of tuberculosis in China. Int J Tuberc Lung Dis 2005, 9(4):450-454.
• [2]Chen J: Internal migration and health: Re-examining the healthy migrant phenomenon in China. Social Science & Medicine 2011, 72(8):1294-301.
• [3]Wei X, Pearson S, Zhang Z, Qin J, Gerein N, Walley J: Comparing knowledge and use of health services of migrants from rural and urban areas in Kunming city, China. J Biosoc Sci 2010, 42(06):743-756.
• [4]Wei X, Chen J, Chen P, Newell JN, Li H, Sun C, Mei J, Walley JD: Barriers to TB care for rural-to-urban migrant TB patients in Shanghai: a qualitative study. Trop Med Int Health 2009, 14(7):754-760.
• [5]Wang W, Jiang Q, Abdullah ASM, Xu B: Barriers in accessing to tuberculosis care among non-residents in Shanghai: a descriptive study of delays in diagnosis. Eur J Public Health 2007, 17(5):419-423.
• [6]Shanghai CDC: Internet-based surveillance data. Shanghai: Shanghai CDC; 2006.
• [7]China National Centre for TB Control and Prevention: China Tuberculosis Prevention and Control Plan: guideline for programme planning and implementation. 2nd edition. Beijing: China Ministry of Health; 2008.
• [8]Narayanan PR, Garg R, Santha T, Paul Kumaran P: Shifting the focus of tuberculosis research in India. Tuberculosis (Edinb) 2003, 83(1):135-142.
• [9]Volmink J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2006, 2:CD003343.
• [10]Garner P, Volmink J: Families help cure tuberculosis. Lancet 2006, 367(9514):878-879.
• [11]Munrom S, Lewin S, Smith H, Engel M, Fretheim A, Volmink J: Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007, 4(7):e238.
• [12]Xu W, Lu W, Zhou Y, Zhu L, Shen H, Wang J: Adherence to anti-tuberculosis treatment among pulmonary tuberculosis patients: a qualitative and quantitative study. BMC Health Serv Res 2009, 9(1):169. BioMed Central Full Text
• [13]Long Q, Smith H, Zhang T, Tang S, Garner P: Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic review. BMC 2011, 11:393.
• [14]Garner P, Smith H, Munro S, Volmink J: Promoting adherence to tuberculosis treatment. Bull World Health Organ 2007, 85(5):404-406.
• [15]Munro S, Lewin S, Swart T, Volmink J: A review of health behaviour theories: how useful are these for developing interventions to promote long-term medication adherence for TB and HIV/AIDS? BMC Public Health 2007, 7:104. BioMed Central Full Text
• [16]World Health Organisation: Section III-Disease-specific reviews-Chapter XV-Tuberculosis. In Adherence to long-term therapies: evidence for action. edn. Gevena: WHO; 2003.
• [17]Sutherland K, Leatherman S, Christianson J: Paying the patient: does it work? A review of patient-targeted incentives. London: The Health Foundation; 2008.
• [18]White MC, Tulsky JP, Reilly P, McIntosh HW, Hoynes TM, Goldenson J: A clinical trial of a financial incentive to go to the tuberculosis clinic for isoniazid after release from jail. Int J Tuberc Lung Dis 1998, 2:6.
• [19]White MC, Tulsky JP, Goldenson J, Portillo CJ, Kawamura M, Menendez E: Randomized Controlled Trial of Interventions to Improve Follow-up for Latent Tuberculosis Infection After Release From Jail. Arch Intern Med 2002, 162(9):1044-1050.
• [20]Tulsky JP, Pilote L, Hahn JA, Zolopa AJ, Burke M, Chesney M, Moss AR: Adherence to Isoniazid Prophylaxis in the Homeless: A Randomized Controlled Trial. Arch Intern Med 2000, 160(5):697-702.
• [21]Tulsky JP, Hahn JA, Long HL, Chambers DB, Robertson MJ, Chesney MA, Moss AR: Can the poor adhere? Incentives for adherence to TB prevention in homeless adults. Int J Tuberc Lung Dis 2004, 8:1.
• [22]Nyamathi AM, Christiani A, Nahid P, Gregerson P, Leake B: A randomized controlled trial of two treatment programs for homeless adults with latent tuberculosis infection. Int J Tuberc Lung Dis 2006, 10:7.
• [23]Pilote L, Tulsky JP, Zolopa AR, Hahn JA, Schecter GF, Moss AR: Tuberculosis Prophylaxis in the Homeless: A Trial to Improve Adherence to Referral. Arch Intern Med 1996, 156(2):161-165.
• [24]Malotte CK, Hollingshead JR, Rhodes F: Monetary versus nonmonetary incentives for TB skin test reading among drug users. Am J Prev Med 1999, 16(3):182-188.
• [25]Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough Lpn L, Metha S, Cavalcante S, Moore RD: A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med 2001, 110(8):610-615.
• [26]Malotte CK, Hollingshead JR, Larro M: Incentives vs. outreach workers for latent tuberculosis treatment in drug users. Am J Prev Med 2001, 20(2):103-107.
• [27]Wei X, Walley J, Zhao J, Yao H, Liu J, Newell J: Why financial incentives did not reach the poor tuberculosis patients? A qualitative study of a Fidelis funded project in Shanxi, China. Health Policy 2009, 90(2–3):206-213.
• [28]Yao H, Wei X, Liu J, Zhao J, Hu D, Walley J: Evaluating the effects of providing financial incentives to tuberculosis patients and health providers in China. Int J Tuberc Lung Dis 2008, 12(10):1166-1172.
• [29]Wang J, Shen H: Review of cigarette smoking and tuberculosis in China: intervention is needed for smoking cessation among tuberculosis patients. BMC Public Health 2009, 9(1):292. BioMed Central Full Text
• [30]Rehm J, Samokhvalov A, Neuman M, Room R, Parry C, Lonnroth K, Patra J, Poznyak V, Popova S: The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009, 9(1):450. BioMed Central Full Text
• [31]Davidson H, Schluger NW, Feldman PH, Valentine DP, Telzak EE, Laufer FN: The effects of increasing incentives on adherence to tuberculosis directly observed therapy. Int J Tuberc Lung Dis 2000, 4:9.
• [32]Beith A, Eichler R, Weil D: Performance-Based Incentives for Health: Way to Improve Tuberculosis Detection and Treatment Completion? The Centre for Global Development 2007.
• [33]Shanghai Bureau for Labor and Social Security: Notice on the minimum salary standard of Shanghai. 2005.
• [34]Tuberculosis Coalition for Technical Assistance: International standards for tuberculosis care (ISTC). The Hague: US CDC, ATS, International Union, KNCV, WHO; 2009.
• [35]Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, et al.: National Survey of Drug-Resistant Tuberculosis in China. N Engl J Med 2012, 366(23):2161-2170.